Delivery Order SPE2DB24D8002-SPE2DB25FJMSS

Award Date 11/18/24
Potential Completion Date 11/19/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,480.37, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. valued at $999,999,999.00. This delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $1,854.34 and is a firm fixed-price Delivery Order contract with a completion date of December 18, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. military, holding a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,674.21 firm fixed price delivery order is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a period of performance through May 9, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division was issued to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,589.50, is a firm fixed-price delivery order to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the DLA. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,479.21 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a performance period through August 15, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,418.80 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of November 8, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces...
This federal contract award, valued at $2,032.02, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The contract requires the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support U.S. Armed Forces medical operations. This award is not set-aside and...
This federal contract award, valued at $1,884.37, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,232.70 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. This contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription pharmaceutical product. The contract has an ultimate completion date of August 8, 2024 and was awarded on August 7, 2024. Dakota Drug, Inc. has a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJMSS
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in the System for Award Management (SAM.gov). The $13,783.74 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a performance period through November 19, 2024 and was awarded on November 18, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which allows the company to provide a wide range of medical products to support U.S. Armed Forces operations. This delivery order is not associated with a set-aside program.

Generated 2/17/25, 9:44 PM